• Title/Summary/Keyword: 정신과치료에 대한 낙인

Search Result 3, Processing Time 0.01 seconds

Mental Health Literacy and Vulnerable Group Analysis of Korea (한국인의 정신건강이해력 평가와 취약집단분석)

  • Seo, Mikyoung;Rhee, Minkyu
    • Korean Journal of Social Welfare
    • /
    • v.65 no.2
    • /
    • pp.313-334
    • /
    • 2013
  • A study aims to assess Korean mental health literacy and analyze the characteristics of vulnerable population. This study presented typical vignettes of schizophrenia, depression and alcoholism to 1,197 adults randomly. All respondents were asked for recognition of mental illness, beliefs about causes, professional help and self-help, stigma for receiving psychiatric treatment for the person described. The results showed that the recognition of mental health problem in a vignette was very poor and that personal causes were seen by public as more important than environmental and bio-genetic causes. When the public were asked about various professional therapies and self-help activities, psychotherapy was favored while other professional help were considered to be less helpful than self-help activities. Among professionals, psychiatrist were viewed as most helpful. We used cluster analysis to compare high mental health literacy group with low mental health literacy group(vulnerable population). Vulnerable population were found to be more aged and to live in county area. We proposed government initiated program for enhancing public mental health literacy.

  • PDF

Integrated Study on Hospitalization Stress Experience of Schizophrenic Patient (조현병 환자의 입원스트레스 경험에 대한 융합연구)

  • Park, Sun Ah;Park, Keun Woo
    • Journal of the Korea Convergence Society
    • /
    • v.9 no.4
    • /
    • pp.397-408
    • /
    • 2018
  • The purpose of this study is to understand and describe the hospitalization stress experience of patients with schizophrenia. The subjects of this study were 15 inpatients who were hospitalized in three psychiatric hospital closure wards. As a result of the study, the contents of hospitalized stress were classified into five categories, 17 sub-categories and 58 meaningful contents. The five top categories were 'missing and guilt for family', 'discomfort due to poor therapeutic environment', 'not respected of rights Patient's, 'anxiety about life after discharge', 'social prejudice and self-perceived stigma. This study has significant implications for the provision of basic data to mediate hospitalization stress of patients with schizophrenia.

NEW DRUG THERAPY IN CHILD AND ADOLESCENT PSYCHIATRY-NEW LONG-ACTING PSYCHOSTIMULANTS (소아청소년 정신과 영역에서의 새로운 약물치료:새로운 장기작용형 중추신경자극제)

  • Choi, Sung-Ku
    • Journal of the Korean Academy of Child and Adolescent Psychiatry
    • /
    • v.14 no.1
    • /
    • pp.3-11
    • /
    • 2003
  • Attention-deficit/Hyperactivity disorder(ADHD) is the most common psychiatric disorder of childhood and among the most prevalent chronic health conditions affecting school-aged children. Children with ADHD experience significant functional problems, such as school difficulties, academic underachievement, troublesome interpersonal relationships with family members and peers, and low self-esteem. The most widely used pharmacological treatments for ADHD are psychostimulants, such as methylphenidate and amphetamine salts. These medications provide clinical efficacy by increasing the availability of catecholamines, primarily dopamine, in the frontal lobe of the brain. immediate-release(IR) formulations of sychostimulants were among the most effective psychotrophic medications in the psychopharmacological treatment. However, there are some limitations of IR formulations:the short half-life and duration of efficacy, which result in the need for multiple daily dosing and the poor compliance. These limitations have led to the development of once-daily, extended-release(ER) formulations of methylphenidate and amphetamine salts. However, these ER formulations may not be as immediately helpful to ADHD children due to delayed onset of action and the acute tolerance which is the failure to sustain the efficacy with the same concentration of drug as the initial stage of medication. OROS-methylphenidate(Concerta$^{\circledR}$) given once a day produces an ascending-pattern plasma drug level generated by the osmotically released, timed drug-delivery system. These new formulations of the psychostimulants have been shown to be a useful alternative to old stimulant medications through the evidence by the clinical trials.

  • PDF